Skip to main content
. Author manuscript; available in PMC: 2017 Aug 1.
Published in final edited form as: Curr Opin Immunol. 2016 Jun 30;41:68–76. doi: 10.1016/j.coi.2016.06.004

Figure 1.

Figure 1

A paradigm switch in T cell therapy. The quest to isolate and expand available T cells from the patient or a donor (left) is giving way to the design and manufacture of engineered T cells with optimized properties (right). See text for abbreviations.